(Alliance News) - The FTSE 100 nursed modest losses on Thursday as doubts grew over the strength and sustainability of the US-Iran ceasefire. Read More
(Alliance News) - GSK PLC on Wednesday said its Exdensur drug, has been approved in China as an add-on therapy for the treatment of chronic rhinosinusitis with nasal polyps. Read More
(Alliance News) - Shell says the Middle East conflict hit output in its Integrated Gas arm, though it sees "significantly higher" trading and optimisation results. GSK announces a drug approval in China, while Close Brothers believes the cost of the final motor finance redress can be "comfortably absorbed". Read More
(Alliance News) - GSK PLC and Shionogi & Co Ltd on Wednesday said the replacement of Pfizer Inc's stake in the ViiV Healthcare Ltd joint venture with an equal investment by Shionogi has been completed. Read More
(Alliance News) - Stock prices in London opened mixed on Monday, ahead of UK mortgage approvals data and as the US and Iran's contrasting statements on the ongoing conflict continue. Read More
(Alliance News) - GSK PLC on Friday said the European Medicines Agency has accepted for review its investigational chronic hepatitis B treatment, bepirovirsen. Read More
(Alliance News) - UK retail sales fell in the month of February but by less than expected, while GSK and AstraZeneca hailed positive clinical and regulatory progress. Herald Investment Trust said it will proceed with a backstop tender offer for up to 100% of shares if no agreement is reached with Saba. Read More
(Alliance News) - Stocks rallied on Wednesday, and oil prices cooled, on hopes for an end to the conflict in the Middle East despite Iran reportedly rejecting a peace plan proposed by the US. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More
(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration approved Lynavoy for the treatment of cholestatic pruritus in patients with primary biliary cholangitis. Read More
(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has gained an age indication expansion from the US Food & Drug Administration. Read More
